Referências

Referências: [1] Kim HY et al. Phosphatidylserine in the brain: metabolism and function. Prog Lipid Res. 2014 Oct;56:1-18, 2014. [2] Ma X et al Phosphatidylserine, inflammation, and central nervous system diseases. Front. Aging Neurosci. 14:975176. 2022. [3] Kang, E.Y et al. Effect of phosphatidylserine on cognitive function in the elderly: A systematic review and meta-analysis. KOREAN J. FOOD SCI. TECHNOL. Vol. 54, No. 1, pp. 52~58, 2022. [4] Glade MJ et al Phosphatidylserine and the human brain. Nutrition. 31(6):781-6, 2015. [5] Chung SY et al. Administration of phosphatidylcholine increases brain acetylcholine concentration and improves memory in mice with dementia. J Nutr. 125(6):1484-9, 1995. [6] Dai Y et al The Crucial Roles of Phospholipids in Aging and Lifespan Regulation. Front Physiol. 23;12:775648, 2021. [7] Chaung HC et al. Docosahexaenoic acid and phosphatidylserine improves the antioxidant activities in vitro and in vivo and cognitive functions of the developing brain. Food Chem. 1;138(1):342-7, 2013. [8] Furushiro M et al. Effects of oral administration of soybean lecithin transphosphatidylated phosphatidylserine on impaired learning of passive avoidance in mice. Jpn J Pharmacol. 75(4):447-50, 1997. [9] Adibhatla RM et al. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 12(1):125-69, 2010. Erratum in: Antioxid Redox Signal.12(2):321, 2010. [10] Hacioglu G Docosahexaenoic acid provides protective mechanism in bilaterally MPTP-lesioned rat model of Parkinsonís disease. Folia Histochem Cytobiol. 50(2):228-38, 2012. [11] Belkouch M et al. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimerís disease. J Nutr Biochem. 38:1-11, 2016. [12] Adibhatla RM et al. Altered lipid metabolism in brain injury and disorders. Subcell Biochem. 49:241-68, 2008. [13] Naureen Z et al. Dietary supplements in neurological diseases and brain aging. J Prev Med Hyg. 17;63(2 Suppl 3):E174-E188, 2022. [14] Monteleone P et al. Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans. Neuroendocrinology. 52(3):243-8, 1990. [15] Monteleone P et al. Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharmacol. 42(4):385-8, 1999. [16] Manor I et al. The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an openlabel extension. Eur Psychiatry 27:335-42, 2012. [17] Baumeister J et al. Influence of phosphatidylserine on cognitive performance and cortical activity after induced stress. Nutr Neurosci. 11(3):103-10, 2008. [18] Hellhammer J et al. Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress. Stress. 7(2):119-26, 2004. [19] Hellhammer J et al. Omega-3 fatty acids administered in phosphatidylserine improved certain aspects of high chronic stress in men. Nutr Res. 32(4):241-50, 2012. [20] Contreras C et al. Omega-3 fatty acids administered in phosphatidylserine improved certain aspects of high chronic stress in men. Nutr Res. 32(4):241-50, 2012. [21] Hellhammer J et al. A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study. Lipids Health Dis. 31;13:121, 2014.